Showing 1 - 10 of 15,880
New drug introductions are a key to growth for pharmaceutical firms. However not all innovations are the same and they may have differential effects that vary by firm size. We use quarterly sales data on UK pharmaceuticals in a dynamic panel model to estimate the impact of product (new drugs)...
Persistent link: https://www.econbiz.de/10012903446
Persistent link: https://www.econbiz.de/10001579254
Persistent link: https://www.econbiz.de/10001190027
Persistent link: https://www.econbiz.de/10011650179
Persistent link: https://www.econbiz.de/10011882454
Persistent link: https://www.econbiz.de/10011863703
Persistent link: https://www.econbiz.de/10012204076
Persistent link: https://www.econbiz.de/10012425881
may even reduce welfare. The reason is that it crowds out proprietary innovation which on net may reduce total innovation … in the long run. These effects would be reinforced if philanthropical innovation diverted people from other productive …
Persistent link: https://www.econbiz.de/10011409970
This paper studies the effect of competition on firm innovation by developing a discrete-time endogenous growth model … where multi-product firms do two types of innovation subject to friction in technology spillovers. Firms improve their … existing products through internal innovation while entering others' product markets through external innovation. We introduce …
Persistent link: https://www.econbiz.de/10013226722